Ticker Details
Insulet Corporation Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
IPO Date:	May 15, 2007
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$10.28B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.94 | 1.99%
Avg Daily Range (30 D):	$3.77 | 2.41%
Avg Daily Range (90 D):	$4.26 | 2.65%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	1.37M
Avg Daily Volume (90 D):	1.26M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	42

Institutional Trades
Total Institutional Trades:	10,426
Avg Institutional Trade:	$6.44M
Avg Institutional Trade (30 D):	$11.64M
Avg Institutional Trade (90 D):	$13.43M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$12M
Avg Closing Trade (30 D):	$30.82M
Avg Closing Trade (90 D):	$37.42M
Avg Closing Volume:	64.26K

News

Aug 24, 2026 @ 1:13 PM Insulet CEO Ashley McEvoy Buys $160,000 in Shares ... Source: Brendan Coffey

Aug 7, 2026 @ 1:45 PM PODD Investors Have Opportunity to Lead Insulet Co... Source: Schall, Brown & Schwartz Llp

Aug 7, 2026 @ 1:32 PM Important Notice to Long-Term Shareholders of Eras... Source: Grabar Law Office

Aug 4, 2026 @ 6:15 PM DEADLINE ALERT for PODD, MVST, HUBG: Law Offices o... Source: Law Offices Of Howard G. Smith

Aug 4, 2026 @ 5:40 PM Deadline Alert: Insulet Corporation (PODD) Shareho... Source: Glancy Prongay Wolke & Rotter Llp

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$5.35	$1.37	$1.3
Diluted EPS	$5.34	$1.37	$1.3
Revenue	$3.05B	$801.7M	$761.7M
Gross Profit	$2.17B	$562.6M	$529.1M
Net Income / Loss	$375.3M	$95M	$91.1M
Operating Income / Loss	$515.8M	$129.7M	$122.1M
Cost of Revenue	$883.2M	$239.1M	$232.7M
Net Cash Flow	$-586.7M	$54.5M	$-235.7M
PE Ratio